Kygevvi (doxecitine and doxribtimine) for thymidine kinase 2 deficiency: a turning point for an ultra-rare mitochondrial disorder

Abstract Purpose Thymidine kinase 2 deficiency (TK2d) is an ultra-rare, autosomal recessive mitochondrial deoxyribonucleic acid (DNA) depletion syndrome. It causes progressive muscle weakness, respiratory failure, and carries high early mortality. Until recently, management was limited to supportive...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Nwamaka Chidera Bob-Ume, Esther Oluwafunmilayo Omotoso, Chizoba Sandra Bob-Ume, JohnPaul Steve Akpabio, Stella Steve Akpabio, Kosisochukwu Chinenye Bob-Ume, Ebelechukwu Isioma Bob-Ume, PraiseGod Monday Ebenezer, Joseph Uso Lot, Precious Nmesomachi Orji, Bernard Dominic Okon, Rita Chinecherem Amaugo, Ediomo Joseph Bright, Abdulhakeem Abdulsalam Oladipupo
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Springer 2026-06-01
Serie:	Journal of Rare Diseases
Soggetti:	Thymidine kinase 2 deficiency TK2d Kygevvi Doxecitine Doxribtimine Mitochondrial DNA depletion syndrome
Accesso online:	https://doi.org/10.1007/s44162-026-00209-y
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!